[1] Herrmann ML, Schleyerbach R, Kirschbaum BJ. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases [J]. Immunopharmacology, 2000, 47(2/3): 273-289. [2] Burger D, Begue-Pastor N, Benavent S, et al. The active metabolite of leflunomide, A771726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes [J]. Rheumatology(Oxford), 2003, 42(1): 89-96. [3] 王小华, 李俊, 王婷玉, 等. A771726体外给药对LPS刺激的胶原性关节炎大鼠腹腔巨噬细胞免疫功能的影响[J]. 安徽医科大学学报, 2009, 44(3): 362-365. [4] 胡国伟, 董群. 大蒜素对白色念珠菌感染的免疫抑制小鼠巨噬细胞功能的影响[J]. 中国临床药理学与治疗学, 2011, 16(3): 270-273. [5] Plüddemann A, Mukhopadhyay S, Gordon S. Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry [J]. Immunol Rev, 2011, 240(1):11-24. [6] Harford KA, Reynolds CM, McGillicuddy FC, et al. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue [J]. Proc Nutr Soc, 2011, 12: 1-10. [7] Ma Y, Wang X, Wu X, et al.(Z)-5-(4-methoxybenzylidene) thiazolidine-2, 4-dione ameliorates the adjuvant-induced arthritis via inhibiting the migration of macrophage and down-regulating the cytokine mRNA expression [J]. Int Immunopharmacol, 2010, 10(11): 1456-1462. [8] Bogdan C, Rollinghoff M, Diefenbach A. The role of nitric oxide in innate immunity [J]. Immunol Rev, 2000, 173: 17-26. [9] 茅尧生, 曹淼英, 周鑫. 强化胰岛素治疗对脓毒症患者血清血管性假血友病因子、内皮素1和一氧化氮浓度及预后的影响[J]. 中国临床药理学与治疗学, 2010, 15(12): 1414-1417. [10] Cook H, Cattell V. Role of nitric oxide in immune-mediated diseases [J]. Clin Sci, 1996, 91(4): 375-384. [11] Wang JX, Hou LF, Yang Y, et al. SM905, an artemisinin derivative, inhibited NO and pro- inflammatory cytokine produced by suppressiong MAPK and NF-κB pathways in RAW 264.7 macrophages [J]. Acta Pharmacol Sin, 2009, 30(10): 1428-1435. |